Arch Venture Fund VII LP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arch Venture Fund VII LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arch Venture Fund VII LP. Arch Venture Fund VII LP is a 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and a 10% Owner in Receptos, Inc. ($RCPT) and a 10% Owner in 908 Devices Inc. ($MASS) and a 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and a 10% Owner in Juno Therapeutics, Inc. ($JUNO) and a 10% Owner in Sage Therapeutics, Inc. ($SAGE).
Address: 8725 WEST HIGGINS ROAD, SUITE 290 CHICAGO 60631 IL
Companies in which Arch Venture Fund VII LP is an Insider
908 Devices Inc.
Industry: MEASURING & CONTROLLING DEVICES, NEC [3829]
Position of Arch Venture Fund VII LP: 10% Owner
Holdings: 5,425,045 shares
Latest Transaction: Dec 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arch Venture Fund VII LP: 10% Owner
Holdings: 3,088,590 shares
Current Value: $137,195,168
Latest Transaction: Feb 23 2015
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Juno Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Arch Venture Fund VII LP: 10% Owner
Holdings: 10,552,390 shares
Current Value: $219,067,616
Latest Transaction: Mar 17 2016
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Receptos, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arch Venture Fund VII LP: 10% Owner
Holdings: 2,058,634 shares
Latest Transaction: May 15 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sage Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arch Venture Fund VII LP: 10% Owner
Holdings: 2,124,699 shares
Current Value: $101,348,142
Latest Transaction: Jun 22 2015
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arch Venture Fund VII LP: 10% Owner
Holdings: 4,302,051 shares
Current Value: $46,978,397
Latest Transaction: Jul 17 2019
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Arch Venture Fund VII LP
Sentiment: All, MASS, AGIO, JUNO, RCPT, SAGE, SYRS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 180,578 | 0 | 0 | |
| Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 665,661 | 0 | 0 | |
| Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 669,977 | 0 | 0 | |
| Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 981,443 | 0 | 0 | |
| Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,927,386 | 0 | 0 | |
| Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Buy | P | 20.00 | 300,000 | 6,000,000 | 5,725,045 | 5.4 M to 5.7 M (+5.53 %) |
| Dec 22 2020 | MASS | 908 Devices Inc. | ARCH Venture Fund VII, L.P. | 10% Owner | Buy | C | 0.00 | 5,425,045 | 0 | 5,425,045 | 0 to 5.4 M |